b12 Labs
b12 makes high-value molecules that are otherwise hard to make. We help pharma companies plan and make new drugs, accelerating early-stage drug discovery from years to months. Andres built the first AI agent that can autonomously think and make molecules in a robotic lab, published in Nature Machine Intelligence (1000+ citations), and won the best paper award at the NeurIPS AI for Science conference. Zlatko is a 3x National Chemistry Olympiad champion, competed at IChO level, and medicinal chemi
Y Combinator
yc-company-directory #3007b12 makes high-value molecules that are otherwise hard to make. We help pharma companies plan and make new drugs, accelerating early-stage drug discovery from years to months. Andres built the first AI agent that can autonomously think and make molecules in a robotic lab, published in Nature Machine Intelligence (1000+ citations), and won the best paper award at the NeurIPS AI for Science conference. Zlatko is a 3x National Chemistry Olympiad champion, competed at IChO level, and medicinal chemi
sourceb12 Labs is classified as AI agents from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to b12 Labs
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Maven Bio
match 69Maven Bio is a 10-person seed-stage team in Boston building the market intelligence layer for life sciences AI. Three of the top 10 pharma companies are onboarded, and we have 20+ enterprise accounts across pharma, consulting, and investing. Customers report a 40% reduction in low-level analytical work. We are growing fast and heading for a Series A. Our buyers are senior BD, CI, Strategy, and Investing leaders.
shared extracted concept terms: pharma, intelligence; shared product terms: pharma, companie, stage, intelligence; shared affiliation: Y Combinator
PostEra
match 67PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discov
shared extracted concept terms: machine; shared product terms: molecule, drug, year, machine; shared affiliation: Y Combinator
Lavo Life Sciences
match 61Lavo Life Sciences runs simulations of drug molecules on computers. Pharma companies use these simulations to guide their experiments and ultimately save time and money in the lab. This will de-risk and expedite clinical trials and FDA approval.
shared extracted concepts: pharma companies; shared product terms: molecule, pharma, companie, drug; shared affiliation: Y Combinator
Framed Data
match 61Predictive analytics for user churn. We use machine learning to help you identify when, and why, your users are leaving. We're building data science tools and predictive analytics solutions for businesses who want value without headcount. Our platform will also include ways for people to collaborate on datasets and analyses. Data science is a high demand field and want to democratize it for all companies to use. Framed Data was acquired by Block in 2016.
shared extracted concept terms: companie, machine; shared product terms: high, value, companie, machine; shared affiliation: Y Combinator
Reticular
match 57Reticular is scaling polygenic prediction for embryo selection, helping IVF couples plan their families today while building a platform to unlock cures for complex heritable diseases long-term. John competed Biology Olympiads before spending 4 years at MIT publishing ML/bio research in NeurIPS and Nature. We believe biological models encode far more information than anyone is currently using - our goal is to unlock this potential.
shared product terms: plan, year, publish, nature; shared affiliation: Y Combinator
Alphagrid
match 54AlphaGrid helps pharma companies identify the right patients for a drug before clinical trials, improving trial success through a reusable drug-to-outcome intelligence platform.
shared extracted concepts: pharma companies; shared product terms: pharma, companie, drug, intelligence